Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

  136,880,248      
Direct Value   $2,440,855,835    

Indirect Value

  $7,314,725,181      
Total Shares   186,710,189      
Total Value   $9,755,581,016      


Neurocrine Biosciences Inc
 $682,662,338 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $51,303,423 Ligand Pharmaceuticals Inc
 $1,290,204,248 Curis Inc
 $3,390,252 Repligen Corp
 $412,241,305 Gyre Therapeutics
 $1,054,262 Neurocrine Biosciences Inc
 $682,662,338 Neurobiological Technologies Inc
 $0 Epirus Biopharmaceuticals Inc
 $7 Adolor Corp
 $0 Dynavax Technologies Corp
 $51,303,423 Ligand Pharmaceuticals Inc
 $1,290,204,248 Curis Inc
 $3,390,252 Repligen Corp
 $412,241,305 Gyre Therapeutics
 $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    19   
    2    

     Stock price went up :

    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-08-13 4 B $8.78 $189,585 I/I 21,600 1,438,333 1.5 -
DVAX Dynavax Technologies Corp Indirect Beneficial Owner   –       –       •   2009-04-27 4 S $1.30 $28,600 I/I (22,000) 8,110,657 0 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-05-28 4 B $4.72 $104,312 I/I 22,100 5,054,800 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-02-28 4 B $5.00 $115,000 I/I 23,000 3,913,100 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-04 4 B $4.97 $115,418 I/I 23,200 4,081,700 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-13 4 B $4.92 $117,531 I/I 23,900 4,678,500 1.5 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-07-25 4 B $8.99 $215,760 I/I 24,000 1,416,733 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-01-09 4 S $6.30 $151,200 I/I (24,000) 1,672,351 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-14 4 B $4.50 $111,600 I/I 24,800 5,955,577 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2009-01-21 4 B $3.06 $77,097 I/I 25,200 5,930,647 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-13 4 B $0.65 $16,550 I/I 25,500 5,084,799 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-05-16 4 B $4.65 $122,358 I/I 26,300 5,027,700 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-07-02 4 B $4.18 $111,098 I/I 26,600 5,081,400 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-01 4 B $0.55 $14,740 I/I 26,800 8,444,799 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-03 4 B $1.95 $54,080 I/I 27,739 13,412,692 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-20 4 B $5.05 $141,905 I/I 28,100 7,923,577 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-12-05 4 B $1.98 $56,065 I/I 28,283 13,537,275 1.5 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-23 4 S $2.75 $79,750 D/D (29,000) 5,845,547 0 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-26 4 S $2.70 $84,249 D/D (31,200) 5,421,547 0 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-30 4 B $2.94 $92,667 I/I 31,500 6,213,551 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-19 4 B $5.10 $164,707 I/I 32,300 7,895,477 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-19 4 B $1.39 $45,906 I/I 33,000 10,777,709 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-03-12 4 B $3.82 $147,452 I/I 38,600 4,700,715 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-01-23 4 B $2.00 $79,456 I/I 39,728 16,002,207 1.5 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2005-01-13 4 S $15.40 $670,978 I/I (43,570) 985,163 -

  195  Records found
  1   2   3  4   5   6   7   8      
  Page 3 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed